Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia

The thrombopoietin receptor agonists (TPO-RAs) are a class of platelet growth factors commonly used to treat immune thrombocytopenia (ITP). There are three agents that have been investigated for the treatment of chronic ITP: the peptide agent romiplostim and the small molecule agents eltrombopag and...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Samkari, Hanny, Kuter, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460888/
https://www.ncbi.nlm.nih.gov/pubmed/31007886
http://dx.doi.org/10.1177/2040620719841735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460888/
https://www.ncbi.nlm.nih.gov/pubmed/31007886
http://dx.doi.org/10.1177/2040620719841735

Ejemplares similares